Search Within

Charles Rudin

Formats
  1. Journal Article (240)
  2. Meeting Abstract (220)
  3. Review (11)
  4. Editorial (10)
  5. Book Section (3)
  6. Guidelines (2)
  7. Research Letter (2)
  8. Correspondence (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (489)
  2. Center for Molecular Imaging and Biotechnology (CMIB) (489)
  3. Department of Medicine (489)
  4. GSK Faculty (489)
  5. Solid Tumor Oncology Division (489)
  6. Thoracic Oncology (489)

More Groups

People
  1. Mark Kris (99)
  2. Natasha Rekhtman (93)
  3. Marc Ladanyi (92)
  4. Gregory Riely (75)
  5. Bob Li (72)
  6. Elisa De Stanchina (70)

More People

Years
  1. 2025 (12)
  2. 2024 (48)
  3. 2023 (43)
  4. 2022 (59)
  5. 2021 (52)
  6. 2020 (50)

More Years

Publications
  1. Journal of Clinical Oncology (82)
  2. Journal of Thoracic Oncology (79)
  3. Clinical Cancer Research (33)
  4. Cancer Research (31)
  5. Annals of Oncology (29)
  6. Cancer Discovery (15)

More Publications

Publishers
  1. Elsevier Inc. (105)
  2. American Society of Clinical Oncology (92)
  3. American Association for Cancer Research (86)
  4. Nature Publishing Group (43)
  5. Oxford University Press (38)
  6. Cell Press (28)

More Publishers

Results (489)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas
    Journal Article

    Selenica, P.; Marra, A.; Choudhury, N. J.; Gazzo, A.; Falcon, C. J.; Patel, J.; Pei, X.; Zhu, Y.; Ng, C. K. Y.; Curry, M.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • 1L durvalumab (D) + platin-etoposid (EP) beim fortgeschrittenen kleinzelligen lungenkarzinom (ES-SCLC): Explorative analyse der molekularen SCLC-subtypen in der caspian-studie
    Meeting Abstract

    Schulz, C.; Xie, M.; Chugh, P.; Broadhurst, H.; Lai, Z.; Whitston, D.; Paz-Ares, L.; Gay, C.; Byers, L.; Rudin, C. M.; more...
    Oncology Research and Treatment (2022)

    Fulltext@MSK | Save
  • Clinicopathologic and mutational landscape of BRAF(V600E)-mutant non-small cell lung carcinoma
    Meeting Abstract

    Sui, J. S. Y.; Ladanyi, M.; Rudin, C. M.; Drilon, A. E.; Riely, G. J.; Kris, M. G.; Offin, M.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • AKT inhibition as a therapeutic strategy to constrain histological transdifferentiation in EGFR-mutant lung adenocarcinoma
    Meeting Abstract

    Quintanal-Villalonga, A.; Taniguchi, H.; Zhan, Y. A.; Egger, J. V.; Bhanot, U.; Qiu, J.; De Stanchina, E.; Rekhtman, N.; Houck-Loomis, B.; Koche, R. P.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Exportin 1 as a therapeutic target against chemoresistance in small cell lung cancer
    Meeting Abstract

    Quintanal-Villalonga, A.; Taniguchi, H.; Hao, Y.; Chow, A.; Zhan, Y. A.; Bhanot, U.; Qiu, J.; de Stanchina, E.; Koche, R. P.; Poirier, J. T.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Minimal residual disease (MRD) detection by ctDNA in relation to radiographic disease progression in patients with stage I-III non-small cell lung cancer (NSCLC) treated with definitive radiation therapy
    Meeting Abstract

    Lebow, E. S.; Murciano-Goroff, Y. R.; Jee, J.; Kalashnikova, E.; Feeney, J.; Sethi, H.; Aleshin, A.; Kris, M. G.; Chaft, J. E.; Rudin, C. M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase I study of entinostat (Ent), atezolizumab (A), carboplatin (C), and etoposide (E) in previously untreated extensive-stage small cell lung cancer (ES-SCLC), ETCTN 10399
    Meeting Abstract

    Gentzler, R. D.; Piekarz, R.; Villaruz, L. C.; Rhee, J. C.; Lai, W. C. V.; Horton, B.; Mock, J.; Hanley, M.; Rudek, M. A.; Phelps, M. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Outcomes of single-agent PD-(L)-1 versus combination with chemotherapy in patients with PD-L1-high (≥ 50%) lung cancer
    Meeting Abstract

    Elkrief, A.; Machado Alessi, J. V.; Ricciuti, B.; Rizvi, H.; Preeshagul, I. R.; Egger, J. V.; Chaft, J. E.; Rudin, C. M.; Riely, G. J.; Kris, M. G.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Clinical outcomes of immune checkpoint inhibitors in HER2-amplified non-small cell lung cancers
    Meeting Abstract

    DeMatteo, R.; Goldman, D. A.; Lin, S. T.; Buonocore, D. J.; Gao, J.; Chang, J. C.; Rekhtman, N.; Offin, M.; Yu, H. A.; Isbell, J. M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Final analysis of consolidative use of radiotherapy to block (CURB) oligoprogression trial - A randomized study of stereotactic body radiotherapy for oligoprogressive metastatic lung and breast cancers
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Eng, J.; Yeh, R.; Girshman, J.; Das, J.; Gelblum, D.; Xu, A. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save